Yesterday, Altamira Therapeutics Ltd. (CYTO) saw a huge uptick after it announced the publication of its Covid-19 nasal spray data in IJMS. The stock rallied
After gaining big on the BentrioTM program’s updates, Altamira Therapeutics Ltd. (CYTO) stock fell under corrections after hours. On December 29, the company provided positive
Altamira Therapeutics Ltd. (CYTO) falls down to $2.20 with a decrease of 5.57% from its last close at $2.33 on November 12. During previous intraday
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.